Non-stimulant treatment for attention deficit hyperactivity disorder.
作者信息
Budur Kumar, Mathews Maju, Adetunji Babatunde, Mathews Manu, Mahmud Jamal
机构信息
Dr. Budur is a fellow in sleep medicine at the Cleveland Clinic Foundation, Cleveland, Ohio.
出版信息
Psychiatry (Edgmont). 2005 Jul;2(7):44-8.
Abstract
摘要
相似文献
1
Non-stimulant treatment for attention deficit hyperactivity disorder.注意缺陷多动障碍的非兴奋剂治疗
Psychiatry (Edgmont). 2005 Jul;2(7):44-8.
2
Managing attention deficit hyperactivity disorder in adults using illicit psychostimulants: A systematic review.使用非法精神兴奋剂治疗成人注意缺陷多动障碍：系统评价。
Aust N Z J Psychiatry. 2017 Sep;51(9):876-885. doi: 10.1177/0004867417714878. Epub 2017 Jun 22.
3
Stimulant medication in ADHD: what do children and their parents say?治疗多动症的兴奋剂药物：儿童及其父母怎么说？
Ir J Psychol Med. 2005 Mar;22(1):5-9. doi: 10.1017/S0790966700008715.
4
Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.注意力缺陷多动障碍药物治疗与较低骨折风险相关：一项回顾性队列研究
Osteoporos Int. 2016 Jul;27(7):2223-2227. doi: 10.1007/s00198-016-3547-1. Epub 2016 Feb 29.
5
Delay Aversion and Executive Functioning in Adults With Attention-Deficit/Hyperactivity Disorder: Before and After Stimulant Treatment.注意缺陷多动障碍成人的延迟厌恶与执行功能：兴奋剂治疗前后。
Int J Neuropsychopharmacol. 2018 Nov 1;21(11):997-1006. doi: 10.1093/ijnp/pyy070.
6
Effectiveness of pharmaceutical therapy of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults - health technology assessment.成人注意力缺陷多动障碍（ADHD）药物治疗的有效性——卫生技术评估
GMS Health Technol Assess. 2010 Sep 7;6:Doc13. doi: 10.3205/hta000091.
7
Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study.使用兴奋剂治疗注意力缺陷多动障碍会导致药物使用/滥用吗？一项为期13年的前瞻性研究。
Pediatrics. 2003 Jan;111(1):97-109. doi: 10.1542/peds.111.1.97.
8
Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder.兴奋剂治疗注意缺陷多动障碍与物质使用障碍的发展风险。
Br J Psychiatry. 2013 Aug;203(2):112-9. doi: 10.1192/bjp.bp.112.124784. Epub 2013 Jul 11.
9
Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.与缓释混合安非他明盐相比，使用盐酸哌甲酯控释片进行兴奋剂治疗对改善患有注意力缺陷多动障碍的青少年驾驶员驾驶性能的相对益处。
Pediatrics. 2006 Sep;118(3):e704-10. doi: 10.1542/peds.2005-2947.
10
Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?注意缺陷多动障碍合并长QT综合征患儿的兴奋剂治疗：一种安全的联合治疗方法？
Heart Rhythm. 2015 Aug;12(8):1807-12. doi: 10.1016/j.hrthm.2015.04.043. Epub 2015 May 5.
引用本文的文献
1
Revisiting the Role of Serotonin in Attention-Deficit Hyperactivity Disorder: New Insights from Preclinical and Clinical Studies.重新审视血清素在注意力缺陷多动障碍中的作用：临床前和临床研究的新见解
Clin Drug Investig. 2025 Sep 3. doi: 10.1007/s40261-025-01473-4.
2
Cardiovascular Risk Associated with the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults.成人注意力缺陷多动障碍治疗相关的心血管风险
Curr Cardiol Rep. 2025 Apr 7;27(1):80. doi: 10.1007/s11886-025-02223-w.
3
4
Prevalence and correlates of common mental disorders among participants of the Uganda Genome Resource: Opportunities for psychiatric genetics research.乌干达基因组资源参与者中常见精神障碍的患病率及其相关因素：精神疾病遗传学研究的机遇
Mol Psychiatry. 2025 Jan;30(1):122-130. doi: 10.1038/s41380-024-02665-8. Epub 2024 Jul 14.
5
The detect consensus report on Attention Deficit/Hyperactivity Disorder and its management among Turkish children and adolescents (Detect: consensus report on ADHD among Turkish youth).土耳其儿童和青少年注意力缺陷/多动障碍及其管理的检测共识报告（检测：土耳其青少年多动症共识报告）
Front Psychiatry. 2024 Mar 20;15:1372341. doi: 10.3389/fpsyt.2024.1372341. eCollection 2024.
6
Potential for a cerebellar role in moderate-late preterm associated behavioural disorders.小脑在中度至晚期早产儿相关行为障碍中的作用潜力。
Front Pediatr. 2024 Jan 26;12:1336137. doi: 10.3389/fped.2024.1336137. eCollection 2024.
7
The Role of Alpha-2 Agonists for Attention Deficit Hyperactivity Disorder in Children: A Review.α-2激动剂在儿童注意力缺陷多动障碍中的作用：综述
Neurol Int. 2023 May 22;15(2):697-707. doi: 10.3390/neurolint15020043.
8
Noradrenergic Modulation of Learned and Innate Behaviors in Dopamine Transporter Knockout Rats by Guanfacine.胍法辛对多巴胺转运体基因敲除大鼠学习和先天行为的去甲肾上腺素能调节作用
Biomedicines. 2023 Jan 15;11(1):222. doi: 10.3390/biomedicines11010222.
9
Viloxazine for Attention-Deficit Hyperactivity Disorder: A Systematic Review and Meta-analysis of Randomized Clinical Trials.用于治疗注意力缺陷多动障碍的维洛沙嗪：随机临床试验的系统评价和荟萃分析
J Cent Nerv Syst Dis. 2022 May 20;14:11795735221092522. doi: 10.1177/11795735221092522. eCollection 2022.
10
Methylphenidate extended-release oral suspension for the treatment of attention-deficit/hyperactivity disorder: a practical guide for pharmacists.用于治疗注意力缺陷/多动障碍的哌甲酯缓释口服混悬液：药剂师实用指南
Integr Pharm Res Pract. 2017 Oct 17;6:163-171. doi: 10.2147/IPRP.S142576. eCollection 2017.
本文引用的文献
1
The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder.患有注意力缺陷多动障碍的男孩抽动障碍的4年病程。
Arch Gen Psychiatry. 1999 Sep;56(9):842-7. doi: 10.1001/archpsyc.56.9.842.
2
Non-stimulant treatment for Attention-Deficit/Hyperactivity Disorder.
J Atten Disord. 2002;6 Suppl 1:S109-19. doi: 10.1177/070674370200601s13.
3
Non-stimulant treatment of attention-deficit/hyperactivity disorder.
CNS Spectr. 2003 Apr;8(4):253-8. doi: 10.1017/s1092852900018460.
4
Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.托莫西汀与哌甲酯治疗儿童注意缺陷多动障碍：一项前瞻性、随机、开放标签试验
J Am Acad Child Adolesc Psychiatry. 2002 Jul;41(7):776-84. doi: 10.1097/00004583-200207000-00008.
5
Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.托莫西汀治疗儿童和青少年注意力缺陷/多动障碍：一项随机、安慰剂对照、剂量反应研究。
Pediatrics. 2001 Nov;108(5):E83. doi: 10.1542/peds.108.5.e83.
6
An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder.托莫西汀治疗小儿注意缺陷多动障碍的开放标签试验。
J Child Adolesc Psychopharmacol. 2001 Summer;11(2):167-70. doi: 10.1089/104454601750284072.
7
Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study.莫达非尼对注意缺陷/多动障碍儿童的影响：一项开放标签研究。
J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):230-5. doi: 10.1097/00004583-200102000-00018.
8
Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults.莫达非尼与右旋苯丙胺治疗成人注意力缺陷多动障碍的疗效比较。
J Child Adolesc Psychopharmacol. 2000 Winter;10(4):311-20. doi: 10.1089/cap.2000.10.311.
9
A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults.安非他酮治疗成人注意力缺陷多动障碍的对照临床试验。
Am J Psychiatry. 2001 Feb;158(2):282-8. doi: 10.1176/appi.ajp.158.2.282.
10
A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder.一项关于去甲替林治疗儿童和青少年注意力缺陷多动障碍的对照研究。
J Child Adolesc Psychopharmacol. 2000 Fall;10(3):193-204. doi: 10.1089/10445460050167304.
Zotero 插件